Variable | Girls(n = 214) | Boys(n = 232) | Total | Test statistic | p- value | |
---|---|---|---|---|---|---|

Diagnosis | Oncologic disease | 171 (79.9%) | 159 (68.5%) | 330 (74%) | χ2 = 14.29 | 0.1600.145^{*} |

CHD | 14 (6.5%) | 17 (7.3%) | 31 (7%) | |||

Nephrotic syndrome | 6 (2.8%) | 15 (6.5%) | 21 (4.7%) | |||

ESRD | 8 (3.7%) | 10 (4.3%) | 18 (4%) | |||

Asthma | 6 (2.8%) | 7 (3%) | 13 (2.9%) | |||

Tricuspid atresia | 3 (1.4%) | 9 (3.9%) | 12 (2.7%) | |||

Down syndrome | 1 (0.5%) | 8 (3.4%) | 9 (2%) | |||

Tetralogy of Fallot | 1 (0.5%) | 3 (1.3%) | 4 (0.9%) | |||

HIV/AIDS | 2 (0.9%) | 1 (0.4%) | 3 (0.7%) | |||

Organ transplant | 1 (0.5%) | 2 (0.9%) | 3 (0.7%) | |||

Cystic fibrosis | 1 (0.5%) | 1 (0.4%) | 2 (0.4%) | |||

Hospitalization time | ≤ 1 w | 131 (61.2%) | 147 (63.4%) | 278 (62.3%) | Z_{U} = -0.98 | 0.328 |

> 1 w & ≤ 1 m | 43 (20.1%) | 55 (23.7%) | 98 (22%) | |||

> 1 m & ≤ 6 m | 16 (7.5%) | 20 (8.6%) | 36 (8.1%) | |||

> 6 m & < 1 y | 7 (3.3%) | 2 (0.9%) | 9 (2%) | |||

≥ 1 y & < 2 y | 3 (1.4%) | 3 (1.3%) | 6 (81.3%) | |||

≥ 2 y | 14 (6.5%) | 5 (2.2%) | 19 (84.3%) | |||

Diagnosis time | < 3 m | 57 (26.6%) | 56 (24.1%) | 113 (25.3%) | Z_{U} = -0.406 | 0.685 |

≥ 3 m & < 6 m | 25 (11.7%) | 23 (9.9%) | 48 (10.8%) | |||

≥ 6 m & < 1 y | 26 (12.1%) | 31 (13.4%) | 57 (12.8%) | |||

≥ 1 y & < 3 y | 32 (15%) | 50 (21.6%) | 82 (18.4%) | |||

≥ 3 y & < 5 y | 36 (16.8%) | 26 (11.2%) | 62 (13.9%) | |||

≥ 5 y & < 10 y | 16 (7.5%) | 22 (9.5%) | 38 (8.5%) | |||

≥ 10 y | 22 (10.3%) | 24 (10.3%) | 46 (10.3%) |